Abstract

Obesity or overweight is associated with diabetes, cardiovascular complications, cancer, and knee replacement surgery. This study aimed to estimate direct healthcare costs of obesity-related complications in Japanese patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Targets for Glycemic Control
S Ali Imran ... Stuart Ross
Canadian Journal of Diabetes | VOL. 37
S Ali Imran, et. al.S Ali Imran ... Stuart Ross
26 Mar 2013
Final analysis of a post-marketing surveillance study of dabrafenib and trametinib combination therapy in Japanese patients with unresectable malignant melanoma with BRAF V600 mutation.
Tomoaki Kaizuka ... Miki Harumiya
The Journal of dermatology | VOL. 50
Tomoaki Kaizuka, et. al.Tomoaki Kaizuka ... Miki Harumiya
08 Mar 2023
Serum Level of Triglycerides Is a Potent Risk Factor Comparable to LDL Cholesterol for Coronary Heart Disease in Japanese Patients with Type 2 Diabetes: Subanalysis of the Japan Diabetes Complications Study (JDCS)
Hirohito Sone ... Yoshimitsu Yamasaki
The Journal of clinical endocrinology and metabolism | VOL. 96
Hirohito Sone, et. al.Hirohito Sone ... Yoshimitsu Yamasaki
24 Aug 2011
Association between mean platelet volume in the pathogenesis of type2 diabetes mellitus and diabetic macrovascular complications in Japanese patients.
Hiroyuki Inoue ... Yoshiaki Kido
Journal of diabetes investigation | VOL. 11
Hiroyuki Inoue, et. al.Hiroyuki Inoue ... Yoshiaki Kido
13 Jan 2020
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
View more papers